K-State licenses technology for coronavirus, norovirus compoundsMarch 2, 2020As global concerns surrounding the novel coronavirus COVID-19 continue to escalate, Kansas State University (K-State) has licensed a technology it says might lead to the production of an antiviral drug treatment.
SPONSORED CONTENTImprove their microbiome, improve quality of lifeWith 70% of a dog’s immune system in the GI tract, you need confidence in their microbiome support — which is why Hill’s developed ActivBiome+. + Learn More
